CiteFacts · FDA Drug Shortages · FDA source
FDA shortage status: Clonazepam Tablet
FDA source answer
FDA currently lists this ingredient in shortage.
FDA source statuses: Current. First FDA posting: 2023-03-10. Latest FDA row update: 2026-10-03.
FDA lists 40 package records, with companies: Accord Healthcare Inc., Advagen Pharma Ltd, Aurobindo Pharma Limited, Aurobindo Pharma USA, Cheplapharm Arzneimittel GmbH, H2-Pharma, LLC, Prinston Pharmaceutical, Inc., Rubicon Research Private Limited, Solco Healthcare LLC, Teva Pharmaceuticals USA, Inc.. Package NDCs: 0093-0832-01, 0093-0832-05, 0093-3212-01, 0093-3212-05, 0093-3213-01, 0093-3213-05, 16729-136-00, 16729-136-16, 16729-137-00, 16729-137-16, 16729-138-00, 16729-138-16, 43547-406-10, 43547-406-11, 43547-406-50, 43547-407-10, 43547-407-11, 43547-407-50, 43547-408-10, 43547-408-50, 59651-722-01, 59651-722-99, 59651-723-01, 59651-723-99, 59651-724-01, 59651-724-05, 61269-605-10, 61269-610-10, 61269-620-10, 72888-152-00, 72888-152-01, 72888-152-05, 72888-152-30, 72888-153-00, 72888-153-01, 72888-153-05, 72888-153-30, 72888-154-01, 72888-154-05, 72888-154-30.
FDA shortage reason: Other
This is nationwide FDA status, not local pharmacy inventory. CiteFacts does not provide medical, treatment, substitution, or dosing advice.
FDA package and manufacturer records
| Company | Package NDC | Presentation | FDA availability field | FDA update |
|---|---|---|---|---|
| Accord Healthcare Inc. | 16729-136-00 | Clonazepam, Tablet, .5 mg (NDC 16729-136-00) | Available | 2026-10-03 |
| Accord Healthcare Inc. | 16729-136-16 | Clonazepam, Tablet, .5 mg (NDC 16729-136-16) | Available | 2026-10-03 |
| Accord Healthcare Inc. | 16729-137-00 | Clonazepam, Tablet, 1 mg (NDC 16729-137-00) | Available | 2026-10-03 |
| Accord Healthcare Inc. | 16729-137-16 | Clonazepam, Tablet, 1 mg (NDC 16729-137-16) | Available | 2026-10-03 |
| Accord Healthcare Inc. | 16729-138-00 | Clonazepam, Tablet, 2 mg (NDC 16729-138-00) | Available | 2026-10-03 |
| Accord Healthcare Inc. | 16729-138-16 | Clonazepam, Tablet, 2 mg (NDC 16729-138-16) | Available | 2026-10-03 |
| Aurobindo Pharma USA | 59651-722-01 | Clonazepam, Tablet, .5 mg (NDC 59651-722-01) | Available | 2026-10-02 |
| Aurobindo Pharma USA | 59651-722-99 | Clonazepam, Tablet, .5 mg (NDC 59651-722-99) | Available | 2026-10-02 |
| Aurobindo Pharma USA | 59651-723-01 | Clonazepam, Tablet, 1 mg (NDC 59651-723-01) | Available | 2026-10-02 |
| Aurobindo Pharma USA | 59651-723-99 | Clonazepam, Tablet, 1 mg (NDC 59651-723-99) | Available | 2026-10-02 |
| Aurobindo Pharma USA | 59651-724-01 | Clonazepam, Tablet, 2 mg (NDC 59651-724-01) | Available | 2026-10-02 |
| Aurobindo Pharma USA | 59651-724-05 | Clonazepam, Tablet, 2 mg (NDC 59651-724-05) | Available | 2026-10-02 |
| Cheplapharm Arzneimittel GmbH | 61269-605-10 | Klonopin, Tablet, .5 mg (NDC 61269-605-10) | Available | 2026-10-02 |
| Cheplapharm Arzneimittel GmbH | 61269-610-10 | Klonopin, Tablet, 1 mg (NDC 61269-610-10) | Available | 2026-10-02 |
| Cheplapharm Arzneimittel GmbH | 61269-620-10 | Klonopin, Tablet, 2 mg (NDC 61269-620-10) | Available | 2026-09-16 |
| Prinston Pharmaceutical, Inc. | 43547-406-10 | Clonazepam, Tablet, .5 mg (NDC 43547-406-10) | Available | 2026-09-02 |
| Prinston Pharmaceutical, Inc. | 43547-406-11 | Clonazepam, Tablet, .5 mg (NDC 43547-406-11) | Available | 2026-09-02 |
| Prinston Pharmaceutical, Inc. | 43547-406-50 | Clonazepam, Tablet, .5 mg (NDC 43547-406-50) | Available | 2026-09-02 |
| Prinston Pharmaceutical, Inc. | 43547-407-10 | Clonazepam, Tablet, 1 mg (NDC 43547-407-10) | Available | 2026-09-02 |
| Prinston Pharmaceutical, Inc. | 43547-407-11 | Clonazepam, Tablet, 1 mg (NDC 43547-407-11) | Available | 2026-09-02 |
| Prinston Pharmaceutical, Inc. | 43547-407-50 | Clonazepam, Tablet, 1 mg (NDC 43547-407-50) | Available | 2026-09-02 |
| Prinston Pharmaceutical, Inc. | 43547-408-10 | Clonazepam, Tablet, 2 mg (NDC 43547-408-10) | Available | 2026-09-02 |
| Prinston Pharmaceutical, Inc. | 43547-408-50 | Clonazepam, Tablet, 2 mg (NDC 43547-408-50) | Available | 2026-09-02 |
| Rubicon Research Private Limited | 72888-152-00 | Clonazepam, Tablet, .5 mg (NDC 72888-152-00) | Available | 2026-06-01 |
| Rubicon Research Private Limited | 72888-152-01 | Clonazepam, Tablet, .5 mg (NDC 72888-152-01) | Available | 2026-06-01 |
| Rubicon Research Private Limited | 72888-152-05 | Clonazepam, Tablet, .5 mg (NDC 72888-152-05) | Available | 2026-06-01 |
| Rubicon Research Private Limited | 72888-152-30 | Clonazepam, Tablet, .5 mg (NDC 72888-152-30) | Available | 2026-06-01 |
| Rubicon Research Private Limited | 72888-153-00 | Clonazepam, Tablet, 1 mg (NDC 72888-153-00) | Available | 2026-06-01 |
| Rubicon Research Private Limited | 72888-153-01 | Clonazepam, Tablet, 1 mg (NDC 72888-153-01) | Available | 2026-06-01 |
| Rubicon Research Private Limited | 72888-153-05 | Clonazepam, Tablet, 1 mg (NDC 72888-153-05) | Available | 2026-06-01 |
| Rubicon Research Private Limited | 72888-153-30 | Clonazepam, Tablet, 1 mg (NDC 72888-153-30) | Available | 2026-06-01 |
| Rubicon Research Private Limited | 72888-154-01 | Clonazepam, Tablet, 2 mg (NDC 72888-154-01) | Available | 2026-06-01 |
| Rubicon Research Private Limited | 72888-154-05 | Clonazepam, Tablet, 2 mg (NDC 72888-154-05) | Available | 2026-06-01 |
| Rubicon Research Private Limited | 72888-154-30 | Clonazepam, Tablet, 2 mg (NDC 72888-154-30) | Available | 2026-06-01 |
| Teva Pharmaceuticals USA, Inc. | 0093-0832-01 | Clonazepam, Tablet, .5 mg (NDC 0093-0832-01) | Available | 2026-10-01 |
| Teva Pharmaceuticals USA, Inc. | 0093-0832-05 | Clonazepam, Tablet, .5 mg (NDC 0093-0832-05) | Available | 2026-10-01 |
| Teva Pharmaceuticals USA, Inc. | 0093-3212-01 | Clonazepam, Tablet, 1 mg (NDC 0093-3212-01) | Limited Availability | 2026-08-17 |
| Teva Pharmaceuticals USA, Inc. | 0093-3212-05 | Clonazepam, Tablet, 1 mg (NDC 0093-3212-05) | Available | 2026-10-01 |
| Teva Pharmaceuticals USA, Inc. | 0093-3213-01 | Clonazepam, Tablet, 2 mg (NDC 0093-3213-01) | Available | 2026-10-01 |
| Teva Pharmaceuticals USA, Inc. | 0093-3213-05 | Clonazepam, Tablet, 2 mg (NDC 0093-3213-05) | Available | 2026-10-01 |
Source facts
Grouped generic ingredient: Clonazepam Tablet · 40 package records
Therapeutic categories: Neurology, Pediatric, Psychiatry
Dosage forms: Tablet
Routes: ORAL
Open FDA source data · JSON · Markdown
FDA is authoritative. Source retrieved 2026-10-06T18:55:41+00:00. Derived grouping is documented in this record's derivations.